Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3220 results found

2023 ∙ Wu, N. Joyal-Desmarais, K. Ribeiro, P. A. B. Vieira, A. M. Stojanovic, J. Sanuade, C. Yip, D. Bacon, S. L.

Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Khan, I. Elsanousi, A. A. Shareef, A. M. Tebha, S. S. Arif, A. Gul, S.

Manifestation of pityriasis rosea and pityriasis rosea-like eruptions after Covid-19 vaccine: A systematic review

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Low
2023 ∙ Marchand, G. Masoud, A. T. Grover, S. King, A. Brazil, G. Ulibarri, H. Parise, J. Arroyo, A. Coriell, C. Goetz, S. Moir, C. Govindan, M. Moberly, A. Proctor, A. Sainz, K. Blumrick, R.

Maternal and neonatal outcomes of COVID-19 vaccination during pregnancy, a systematic review and meta-analysis

  • Pregnant women
  • COVID-19
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Santangelo, O. E. Provenzano, S. Grigis, D. Ferrara, C. Cedrone, F. Firenze, A.

Menstrual changes after COVID-19 vaccine administration: a systematic review

  • Adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Low
2023 ∙ Neophytou, P. Artemiadis, A. Hadjigeorgiou, G. M. Zis, P.

Miller Fischer syndrome after COVID-19 infection and vaccine: a systematic review

  • Adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Mirmosayyeb, O. Ghaffary, E. M. Vaheb, S. Pourkazemi, R. Shaygannejad, V.

Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccines: A systematic review

  • Adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Elsaid, M. Nune, A. Hesham, D. Fouad, F. M. Hassan, H. Hamouda, H. Sherif, H. Abdelwahab, M. M. Hegazi, N. El-Rahman, Y. A.

Multisystem Inflammatory Syndrome (MIS) following SARS-CoV-2 vaccinations; a systematic review

  • Adolescents
  • Adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Low
2023 ∙ Saputra, P. B. T. Kurniawan, R. B. Trilistyoati, D. Farabi, M. J. A. Susilo, H. Alsagaff, M. Y. Oktaviono, Y. H. Sutanto, H. Gusnanto, A. Dyah Kencono Wungu, C.

Myocarditis and coronavirus disease 2019 vaccination: A systematic review and meta-summary of cases

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Low
2023 ∙ Shaheen, N. Ramadan, A. Shaheen, A. Elmasry, M. Swed, S. Hafez, W. Wael, M.

Myocarditis Following COVID-19 Vaccination: A Systematic Review

  • Adolescents
  • Adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Thaker, R. Faraci, J. Derti, S. Schiavone, J. F.

Myocarditis in SARS-CoV-2: A Meta-Analysis

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
Loading...